title: [Macular damage in Behçet's disease].
abstract: BACKGROUND
  The macular damage in Behçet's disease requires particular attention because of its poor prognosis.
  
  
  OBJECTIVE
  The purpose of our study was to specify the frequency of macular alterations in Behçet's disease and discuss the clinical, physiopathological and therapeutic aspects.
  
  
  METHODS
  Our report is based on 244 patients with Behçet's disease examined between January 1995 and December 1997. The authors studied macular alterations in detail.
  
  
  RESULTS
  Sixty-nine patients had a maculopathy affecting 108 out of 432 eyes (24%). The mean progression of Behçet's disease in these cases was 4 years. Visual acuity was<or=2/10e in 48 eyes (44.4%). Maculopathy was bilateral in 39 cases. Macular edema was the most frequently noted form in 62% of the eyes, followed by cystoid macular edema (17%) and macular hole (3.4%).
  
  
  CONCLUSIONS
  Macular edema is the most frequent sign and complication arising from the macular area during Behçet's disease, which can evolve into cystoid degenerescence and occasionally macular hole. Macular lesions are often irreversible, making prognosis uncertain, despite the various treatments available.
  
  
  CONCLUSIONS
  Macular damage is the major cause of visual morbidity in patients with Behçet's disease and should be systematically sought.
authors.affiliation: Service d'Ophtalmologie, Hôpital 20 Août, Casablanca, Maroc.
authors.forename: O
authors.initials: O
authors.lastname: Benchekroun
authors.forename: D
authors.initials: D
authors.lastname: Lahbil
authors.forename: H
authors.initials: H
authors.lastname: Lamari
authors.forename: R
authors.initials: R
authors.lastname: Rachid
authors.forename: M
authors.initials: M
authors.lastname: El Belhadji
authors.forename: N
authors.initials: N
authors.lastname: Laouissi
authors.forename: K
authors.initials: K
authors.lastname: Zaghloul
authors.forename: S
authors.initials: S
authors.lastname: Benamour
authors.forename: A
authors.initials: A
authors.lastname: Amraoui
mesh_terms: D000328:Adult; D001528:Behcet Syndrome / Q000150:complications*; D005260:Female; D006801:Humans; D008268:Macular Degeneration / Q000453:epidemiology* / Q000209:etiology / Q000628:therapy; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies